Maki Umemura
Biographic Data
| ID | 3959585 |
|---|---|
| NAME | Maki Umemura |
| GIVEN NAMES | Maki |
| FAMILY NAME | Umemura |
| SIGNATURE | UMEMURA M |
| AFFILIATIONS | Cardiff University |
| ORCID | 0000-0002-1623-099X |
| VERIFIED | Yes |
| TOTAL WORKS | 12 |
| TOTAL CITATIONS | 13 |
| AUTHOR COUNT | 12 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1958 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 2 |
Translating Emergent Technologies into Novel Therapeutics: Tracing Complementarity and Co-evolution in the Cambridge–Boston Innovation Ecosystem
This article traces the history of the life sciences business in the Cambridge–Boston area and explores how it became the global epicenter of the modern therapeutics industry. While business history scholarship on therapeutics is extensive, few have studied recent technological modalities—from therapeutic proteins to cell and gene therapies—or adopted a regional ecosystem perspective. Based on archival materials and oral histories, this research …
The defence of cosmopolitan capitalism by Sir Charles Addis, 1914-1919: A microhistorical study of a classical liberal banker in wartime
This study focuses on the efforts of Sir Charles Addis to defend the pre-1914 system of cosmopolitan capitalism. Our central research question is to understand why this merchant banker fought in preserve cosmopolitan capitalism when so many of his peers acquiesced in and even championed its demise. Addis’s moral ideal was an international economic order in which the nationality of firms was irrelevant to the strategies of managers. The First Worl…
Shifting patterns of expectations management in innovation policy: A comparative analysis of solar energy policy in the United States, Japan and Germany
Challenging the Problem of ‘Fit’: Advancing the Regenerative Medicine Industries in the United States, Britain and Japan
This article follows the evolution of biopharmaceutical firms as they bore great uncertainty and risks in their endeavours to commercialise new therapies – through the regenerative medicine industry in the United States, Britain and Japan. Despite its beginnings in the 1970s, regenerative medicines have yet to become a widely accepted form of medicine. A large part of the problem lay with the lack of ‘fit’ with the broader health context. This ar…
Prospects for a transparency revolution in the field of business history
The last five years have seen is an increasing emphasis on research transparency in many disciplines. Unfortunately, the field of business history is being bypassed by the movement for the creation of research transparency institutions. The article begins by showing why it is important for the business history community to engage with the research transparency movement by embracing the principle of Open Data. The article then argues that Active C…
Reaching for global in the Japanese cosmetics industry, 1951 to 2015: The case of Shiseido
This article examines the various factors that have shaped the internationalisation of the Japanese cosmetics industry over six decades of economic transformation from 1951 to 2015. Whilst Japanese cosmetics companies have expanded overseas, their focus has largely been in Asia. This article advances a multifactorial explanation that analyses a number of factors that led to regionalisation, including foreign consumers’ perception of Japan, manage…
Rethinking innovative competences at the technological frontier: The Japanese and British experience in regenerative medicine
Cet article compare l’histoire de l’industrie de la médecine régénérative au Royaume-Uni et au Japon. Il s’appuie sur des travaux d’histoire des entreprises dans le domaine thérapeutique et s’inscrit dans le cadre des recherches comparatives en matière de fonctionnement des entreprises et d’analyse institutionnelle, dans lequel des liens sont régulièrement établis entre environnements institutionnels et développement de compétences et de position…
Rethinking innovative competences at the technological frontier: The Japanese and British experience in regenerative medicine
Crisis and change in the system of innovation: The Japanese pharmaceutical industry during the Lost Decades, 1990–2010
This article uses the experience of the Japanese pharmaceutical industry to show how Japan's national system of innovation evolved from a closed, firm-based domestic system toward a more open, networked, global system. This occurred in the face of a crisis of economic and technological dimensions. During the Lost Decades, the nature of innovation in this industry shifted from incremental toward more radical innovation, as the system international…
A second-tier performance: Reflections on Japan's pharmaceutical industry, 1945–2005
While Japan has led the world in certain high-technology industries, such as automobiles and electronics, it has remained a minor player in the global pharmaceutical industry. Japan's leading pharmaceutical firms invest less in R&D and record lower sales than leading global firms. Japan remains a net importer of pharmaceuticals and few Japanese drugs are found outside the country. The global pharmaceutical industry is led by firms from the United…
Reconsidering Japan's Underperformance in Pharmaceuticals: Evidence from Japan's Anticancer Drug Sector
Unlike its automobile or electronics industries, Japan's pharmaceutical industry did not become a global leader. Japan remains a net importer of pharmaceuticals and has introduced few global blockbuster drugs. Alfred Chandler argued that Japan's pharmaceutical firms remained relatively weak because Western firms enjoyed an insurmountable first first-mover advantage. However, this case study of the anticancer drug sector illustrates that Chandler'…
The Growth Rate of the Japanese Economy Since 1878
Prospects for a transparency revolution in the field of business history
The last five years have seen is an increasing emphasis on research transparency in many disciplines. Unfortunately, the field of business history is being bypassed by the movement for the creation of research transparency institutions. The article begins by showing why it is important for the business history community to engage with the research transparency movement by embracing the principle of Open Data. The article then argues that Active C…
The defence of cosmopolitan capitalism by Sir Charles Addis, 1914-1919: A microhistorical study of a classical liberal banker in wartime
This study focuses on the efforts of Sir Charles Addis to defend the pre-1914 system of cosmopolitan capitalism. Our central research question is to understand why this merchant banker fought in preserve cosmopolitan capitalism when so many of his peers acquiesced in and even championed its demise. Addis’s moral ideal was an international economic order in which the nationality of firms was irrelevant to the strategies of managers. The First Worl…
Shifting patterns of expectations management in innovation policy: A comparative analysis of solar energy policy in the United States, Japan and Germany
Reaching for global in the Japanese cosmetics industry, 1951 to 2015: The case of Shiseido
This article examines the various factors that have shaped the internationalisation of the Japanese cosmetics industry over six decades of economic transformation from 1951 to 2015. Whilst Japanese cosmetics companies have expanded overseas, their focus has largely been in Asia. This article advances a multifactorial explanation that analyses a number of factors that led to regionalisation, including foreign consumers’ perception of Japan, manage…
Crisis and change in the system of innovation: The Japanese pharmaceutical industry during the Lost Decades, 1990–2010
This article uses the experience of the Japanese pharmaceutical industry to show how Japan's national system of innovation evolved from a closed, firm-based domestic system toward a more open, networked, global system. This occurred in the face of a crisis of economic and technological dimensions. During the Lost Decades, the nature of innovation in this industry shifted from incremental toward more radical innovation, as the system international…
Rethinking innovative competences at the technological frontier: The Japanese and British experience in regenerative medicine
Cet article compare l’histoire de l’industrie de la médecine régénérative au Royaume-Uni et au Japon. Il s’appuie sur des travaux d’histoire des entreprises dans le domaine thérapeutique et s’inscrit dans le cadre des recherches comparatives en matière de fonctionnement des entreprises et d’analyse institutionnelle, dans lequel des liens sont régulièrement établis entre environnements institutionnels et développement de compétences et de position…
The Growth Rate of the Japanese Economy Since 1878
Reconsidering Japan's Underperformance in Pharmaceuticals: Evidence from Japan's Anticancer Drug Sector
Unlike its automobile or electronics industries, Japan's pharmaceutical industry did not become a global leader. Japan remains a net importer of pharmaceuticals and has introduced few global blockbuster drugs. Alfred Chandler argued that Japan's pharmaceutical firms remained relatively weak because Western firms enjoyed an insurmountable first first-mover advantage. However, this case study of the anticancer drug sector illustrates that Chandler'…
A second-tier performance: Reflections on Japan's pharmaceutical industry, 1945–2005
While Japan has led the world in certain high-technology industries, such as automobiles and electronics, it has remained a minor player in the global pharmaceutical industry. Japan's leading pharmaceutical firms invest less in R&D and record lower sales than leading global firms. Japan remains a net importer of pharmaceuticals and few Japanese drugs are found outside the country. The global pharmaceutical industry is led by firms from the United…
Crisis and change in the system of innovation: The Japanese pharmaceutical industry during the Lost Decades, 1990–2010
This article uses the experience of the Japanese pharmaceutical industry to show how Japan's national system of innovation evolved from a closed, firm-based domestic system toward a more open, networked, global system. This occurred in the face of a crisis of economic and technological dimensions. During the Lost Decades, the nature of innovation in this industry shifted from incremental toward more radical innovation, as the system international…
Rethinking innovative competences at the technological frontier: The Japanese and British experience in regenerative medicine
Cet article compare l’histoire de l’industrie de la médecine régénérative au Royaume-Uni et au Japon. Il s’appuie sur des travaux d’histoire des entreprises dans le domaine thérapeutique et s’inscrit dans le cadre des recherches comparatives en matière de fonctionnement des entreprises et d’analyse institutionnelle, dans lequel des liens sont régulièrement établis entre environnements institutionnels et développement de compétences et de position…
Rethinking innovative competences at the technological frontier: The Japanese and British experience in regenerative medicine
Reaching for global in the Japanese cosmetics industry, 1951 to 2015: The case of Shiseido
This article examines the various factors that have shaped the internationalisation of the Japanese cosmetics industry over six decades of economic transformation from 1951 to 2015. Whilst Japanese cosmetics companies have expanded overseas, their focus has largely been in Asia. This article advances a multifactorial explanation that analyses a number of factors that led to regionalisation, including foreign consumers’ perception of Japan, manage…
Challenging the Problem of ‘Fit’: Advancing the Regenerative Medicine Industries in the United States, Britain and Japan
This article follows the evolution of biopharmaceutical firms as they bore great uncertainty and risks in their endeavours to commercialise new therapies – through the regenerative medicine industry in the United States, Britain and Japan. Despite its beginnings in the 1970s, regenerative medicines have yet to become a widely accepted form of medicine. A large part of the problem lay with the lack of ‘fit’ with the broader health context. This ar…
Prospects for a transparency revolution in the field of business history
The last five years have seen is an increasing emphasis on research transparency in many disciplines. Unfortunately, the field of business history is being bypassed by the movement for the creation of research transparency institutions. The article begins by showing why it is important for the business history community to engage with the research transparency movement by embracing the principle of Open Data. The article then argues that Active C…
Shifting patterns of expectations management in innovation policy: A comparative analysis of solar energy policy in the United States, Japan and Germany
The defence of cosmopolitan capitalism by Sir Charles Addis, 1914-1919: A microhistorical study of a classical liberal banker in wartime
This study focuses on the efforts of Sir Charles Addis to defend the pre-1914 system of cosmopolitan capitalism. Our central research question is to understand why this merchant banker fought in preserve cosmopolitan capitalism when so many of his peers acquiesced in and even championed its demise. Addis’s moral ideal was an international economic order in which the nationality of firms was irrelevant to the strategies of managers. The First Worl…
Translating Emergent Technologies into Novel Therapeutics: Tracing Complementarity and Co-evolution in the Cambridge–Boston Innovation Ecosystem
This article traces the history of the life sciences business in the Cambridge–Boston area and explores how it became the global epicenter of the modern therapeutics industry. While business history scholarship on therapeutics is extensive, few have studied recent technological modalities—from therapeutic proteins to cell and gene therapies—or adopted a regional ecosystem perspective. Based on archival materials and oral histories, this research …
Economics (9 works) · Business (6 works) · Political science (5 works) · Marketing (4 works) · Economy (3 works) · Industrial organization (3 works) · International trade (3 works) · Marketing (3 works) · Pharmaceutical industry (3 works) · Sociology (3 works)